|
1 |
22 05 2026 |
India seeks industry inputs on Canada market access barriers as CEPA negotiations gain momentum |
Pharmabiz |
India |
|
2 |
22 05 2026 |
HAB Pharma entering next growth phase with complex molecules, differentiated delivery formats: Urvee Garg |
Pharmabiz |
India |
|
3 |
22 05 2026 |
CDSCO declares 169 drug samples as NSQs, one as spurious in April |
Pharmabiz |
India |
|
4 |
22 05 2026 |
Paracetamol, Azithromycin among 300 essential drugs likely to see temporary price rise |
Medical Dialogues |
India |
|
5 |
22 05 2026 |
Indian pharma fuels Africa’s ‘zombie drug’ and opioid crisis |
Japan Times |
India |
|
6 |
22 05 2026 |
India Must Build Trust, Speed Up Approvals to Become Global Clinical Trials Hub:ISCR PRESIDENT |
Health world (Economic Times) |
India |
|
7 |
22 05 2026 |
ICMR replaces old system with single window approval for medical studies |
Health world (Economic Times) |
India |
|
8 |
22 05 2026 |
Bihar CDA steps up campaign against regulatory loopholes governing e-pharmacy operations |
Pharmabiz |
India |
|
9 |
21 05 2026 |
Industry hails CDCSO’s recent decision to allow parallel submission & processing of clinical trial applications |
Pharmabiz |
India |
|
10 |
21 05 2026 |
DoP invites pharma firms to join Taiwan collaboration drive for R&D, manufacturing & technology partnerships |
Pharmabiz |
India |
|
11 |
21 05 2026 |
CDSCO seeks public to report violation of rules in cosmetics segment |
Pharmabiz |
India |
|
12 |
21 05 2026 |
Hyderabad & Bengaluru airports anchor South India’s pharma export ecosystem |
Pharmabiz |
India |
|
13 |
21 05 2026 |
CDSCO debars Nagpur-based DMF Cosmo from applying for registration to import cosmetics |
Pharmabiz |
India |
|
14 |
21 05 2026 |
Dr Reddy’s Labs launches oral semaglutide biosimilar ‘Obeda’ tablets in India |
Pharmabiz |
India |
|
15 |
21 05 2026 |
Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost |
Health Policy |
Switzerland |
|
16 |
21 05 2026 |
Widely used asthma drug may improve performance of cancer immunotherapies |
Health world (Economic Times) |
India |
|
17 |
21 05 2026 |
Beyond scale: Rethinking new frontiers in building excellence |
Express Pharma |
India |
|
18 |
21 05 2026 |
MSME Pharma firms warn of rising compliance burden as regulatory costs surge: FOPE Study |
Express Pharma |
India |
|
19 |
21 05 2026 |
Telangana DCA finds violations in 144 Pharmacies during statewide inspection drive |
Medical Dialogues |
India |
|
20 |
20 05 2026 |
India reviews preparedness after WHO declares Ebola global health emergency |
Medical Dialogues |
India |
